ASR Vermogensbeheer’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Buy
138,302
+41,996
+44% +$3.67M 0.13% 156
2026
Q1
$8.21M Buy
96,306
+2,125
+2% +$189K 0.1% 191
2025
Q4
$7.44M Sell
94,181
-815
-0.9% -$63.9K 0.09% 198
2025
Q3
$7.59M Sell
94,996
-364
-0.4% -$31.1K 0.09% 190
2025
Q2
$8.67M Sell
95,360
-2,259
-2% -$206K 0.11% 174
2025
Q1
$9.15M Buy
+97,619
New +$8.74M 0.14% 149

Other funds holding CL

ASR Vermogensbeheer's CL Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Colgate-Palmolive (CL) stake by 44% in Q2 2026, buying an estimated $3.67M and bringing the position to 138,302 shares worth $12.7M. The position accounts for 0.13% of the portfolio, ranked #156.

ASR Vermogensbeheer first reported a position in CL in Q1 2025 and has held it in 6 quarters since. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • ASR Vermogensbeheer held 138,302 shares of Colgate-Palmolive worth $12.7M as of Q2 2026.
  • ASR Vermogensbeheer bought 41,996 Colgate-Palmolive shares in Q2 2026, an estimated $3.67M.
  • Colgate-Palmolive made up 0.13% of ASR Vermogensbeheer's portfolio in Q2 2026, its #156 holding.
  • ASR Vermogensbeheer first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 6 quarters since.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.